Pfizer to review U.S. Treasury notice, Bloomberg says A Pfizer spokesperson in an e-mailed statement said it was conducting a review of the U.S. Treasury's notice, says Bloomberg. Pfizer says it will not speculate on potential effect until review is over, added Bloomberg
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.